Clinical Trial Update: Hydrogen In Neonatal Encephalopathy (HIE) Trial [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing hydrogen therapy for neonatal hypoxic-ischemic encephalopathy is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Hydrogen (hydrogen gas)

Snippet

Sponsor: Boston Children's Hospital | Conditions: HIE, Hypoxic-Ischemic Encephalopathy | Phase 1 | Status: NOT_YET_RECRUITING